Is Adial Pharmaceuticals Inc (ADIL) Stock at the Top of the Biotechnology Industry?

Adial Pharmaceuticals Inc (ADIL) is around the top of the Biotechnology industry according to InvestorsObserver. ADIL received an overall rating of 51, which means that it scores higher than 51 percent of all stocks. Adial Pharmaceuticals Inc also achieved a score of 72 in the Biotechnology industry, putting it above 72 percent of Biotechnology stocks. Biotechnology is ranked 78 out of the 148 industries.

ADIL has an Overall Score of 51. Find out what this means to you and get the rest of the rankings on ADIL!

See Full ADIL Report

What do These Ratings Mean?

Analyzing stocks can be hard. There are tons of numbers and ratios, and it can be hard to remember what they all mean and what counts as “good” for a given value. InvestorsObserver ranks stocks on eight different metrics. We percentile rank most of our scores to make it easy for investors to understand. A score of 51 means the stock is more attractive than 51 percent of stocks. Our proprietary scoring system captures technical factors, fundamental analysis and the opinions of analysts on Wall Street. This makes InvestorsObserver’s overall rating a great way to get started, regardless of your investing style. Percentile-ranked scores are also easy to understand. A score of 100 is the top and a 0 is the bottom. There’s no need to try to remember what is “good” for a bunch of complicated ratios, just pay attention to which numbers are the highest.

What's Happening With Adial Pharmaceuticals Inc Stock Today?

Adial Pharmaceuticals Inc (ADIL) stock has fallen -7.37% while the S&P 500 has risen 0.26% as of 10:03 AM on Wednesday, Sep 27. ADIL has fallen -$0.23 from the previous closing price of $3.12 on volume of 41,869 shares. Over the past year the S&P 500 is up 17.48% while ADIL has fallen -70.21%. ADIL lost -$7.45 per share the over the last 12 months. Click Here to get the full Stock Report for Adial Pharmaceuticals Inc stock.